Correlation Between Nautilus Biotechnology and Arcellx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nautilus Biotechnology and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nautilus Biotechnology and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nautilus Biotechnology and Arcellx, you can compare the effects of market volatilities on Nautilus Biotechnology and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nautilus Biotechnology with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nautilus Biotechnology and Arcellx.

Diversification Opportunities for Nautilus Biotechnology and Arcellx

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nautilus and Arcellx is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Nautilus Biotechnology and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Nautilus Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nautilus Biotechnology are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Nautilus Biotechnology i.e., Nautilus Biotechnology and Arcellx go up and down completely randomly.

Pair Corralation between Nautilus Biotechnology and Arcellx

Given the investment horizon of 90 days Nautilus Biotechnology is expected to under-perform the Arcellx. In addition to that, Nautilus Biotechnology is 1.23 times more volatile than Arcellx. It trades about -0.11 of its total potential returns per unit of risk. Arcellx is currently generating about -0.11 per unit of volatility. If you would invest  8,499  in Arcellx on October 26, 2024 and sell it today you would lose (1,914) from holding Arcellx or give up 22.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Nautilus Biotechnology  vs.  Arcellx

 Performance 
       Timeline  
Nautilus Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nautilus Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Arcellx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcellx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nautilus Biotechnology and Arcellx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nautilus Biotechnology and Arcellx

The main advantage of trading using opposite Nautilus Biotechnology and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nautilus Biotechnology position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.
The idea behind Nautilus Biotechnology and Arcellx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges